Michelle Petri, MD, MPH
Disclosures: Grant or research support-AstraZeneca|Grant or research support-Aurinia|Grant or research support-Eli Lilly and Company|Grant or research support-Exagen|Grant or research support-GlaxoSmithKline|Grant or research support-Johnson and Johnson|Grant or research support-Thermofisher|Consulting Fee-Alexion (Relationship has ended)|Consulting Fee-Amgen|Consulting Fee-AstraZeneca|Consulting Fee-Aurinia|Consulting Fee-Axdev (Relationship has ended)|Consulting Fee-Boston Pharmaceuticals (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Emergent Biosolutions|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-GlaxoSmithKline|Membership on Advisory Committees or Review Panels, Board Membership, etc.-IQVIA|Consulting Fee-Idorsia Pharmaceuticals (Relationship has ended)|Consulting Fee-Janssen|Consulting Fee-Kezar Life Sciences (Relationship has ended)|Consulting Fee-Eli Lilly and Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-EMD Serono|Consulting Fee-Momenta Pharmaceuticals (Relationship has ended)|Consulting Fee-PPD Development (Relationship has ended)|Consulting Fee-Sanofi-Aventis (Relationship has ended)|Consulting Fee-UCB (Relationship has ended)|Consulting Fee-AnaptysBio|Consulting Fee-Argenx|Consulting Fee-Biogen Idec|Consulting Fee-Caribou Biosciences|Consulting Fee-CVS Health|Consulting Fee-Kira Pharmaceuticals|Consulting Fee-MedShr (Relationship has ended)|Consulting Fee-Sanofi-Aventis (Relationship has ended)|Consulting Fee-SinoMab Biosciences - 04/18/2022
No Bio Available.